Multiple sclerosis (experimental) is treatable*
For a long time, multiple sclerosis was viewed as an unstoppable act of destruction by one’s own immune system, in which the vital protective sheaths of the nerve fibers are irretrievably worn away. Those affected faced a chronic, progressive deterioration that was primarily designed for damage control. Thanks to experimental regenerative protocols, this picture is fundamentally changing: the goal is shifting from mere inflammation inhibition to active repair and reconstruction of the destroyed nerve sheaths.
How we treat multiple sclerosis and what improvements can be achieved*
As part of modern experimental protocols, we combine immunomodulatory and regenerative approaches. Our goal is to break the autoinflammatory cascade and stimulate the body’s own repair mechanisms for the nerve sheaths.
What is the scientific background*
Autoimmune inflammatory processes destroy the myelin sheath of nerve fibers in the central nervous system. Experimental regenerative approaches aim to stop inflammation and stimulate remyelination (repair of the nerve sheaths).
* The contents serve to provide understandable orientation and do not replace individual medical advice. Indication, implementation and chances of success are always personally checked by a doctor.